Ahmed Abdrabou
- Drug Discovery top 5%
- Molecular Medicine top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 6
- Pharmaceutical Science top 5%
- Biophysics top 5%
-
- Synthesis and biological activity 14
- Synthesis and Characterization of Heterocyclic Compounds 8
-
- Hepatitis C virus research 8
-
- Computational Drug Discovery Methods 7
-
- Tannin, Tannase and Anticancer Activities 7
-
- Cancer-related Molecular Pathways 6
-
- Cell death mechanisms and regulation 6
- Co-authors
- Hanaa H. AhmedAziza B. ShalbyKhairy M. A. ZoheirAlaa RefaatAmr E. EdrisIbrahim M. El‐SherbinyNancy M. ElbazIslam A. Khalil
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Ahmed Abdrabou
88 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Drug Discovery 3
- Molecular Medicine 70
- Biomaterials 153
- Pharmaceutical Science 64
- Biophysics 60
Countries citing papers authored by Ahmed Abdrabou
This map shows the geographic impact of Ahmed Abdrabou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Abdrabou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Abdrabou more than expected).
Fields of papers citing papers by Ahmed Abdrabou
This network shows the impact of papers produced by Ahmed Abdrabou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Abdrabou. The network helps show where Ahmed Abdrabou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed Abdrabou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 7 | |
| 7 | 2024 | 14 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 40 | |
| 16 | 2019 | 22 | |
| 17 | 2018 | 24 | |
| 18 | 2016 | 13 | |
| 19 | 2015 | 49 | |
| 20 | 2012 | 2 |
About Ahmed Abdrabou
Ahmed Abdrabou is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Toxicology, having authored 90 papers that have together received 1.3k indexed citations. Recurring topics across this work include Synthesis and biological activity (14 papers), Hepatitis C virus research (8 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers), Computational Drug Discovery Methods (7 papers), Tannin, Tannase and Anticancer Activities (7 papers), Cancer-related Molecular Pathways (6 papers), Nanoparticle-Based Drug Delivery (6 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Drug Discovery (3 citations), Molecular Medicine (70 citations) and Biomaterials (153 citations). Ahmed Abdrabou has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Hanaa H. Ahmed, Aziza B. Shalby, Khairy M. A. Zoheir, Alaa Refaat, Amr E. Edris, Ibrahim M. El‐Sherbiny, Nancy M. Elbaz, Islam A. Khalil, Emad F. Eskander and Shaker A. Mousa. Their work appears in journals such as Scientific Reports, Molecules and Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.